1-(5-(tert-Butyl)isoxazol-3-yl)-3-(2-(trifluoromethyl)phenyl)urea

Catalog No. :
ACCFTS103
CAS No. :
304440-06-0
Molecular Formula :
C15H16F3N3O2
Molecular Weight :
327.31

IUPAC Name:1-(5-(tert-butyl)isoxazol-3-yl)-3-(2-(trifluoromethyl)phenyl)urea

1-(5-(tert-Butyl)isoxazol-3-yl)-3-(2-(trifluoromethyl)phenyl)urea structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$599.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(5-(tert-Butyl)isoxazol-3-yl)-3-(2-(trifluoromethyl)phenyl)urea
IUPAC Name1-(5-(tert-butyl)isoxazol-3-yl)-3-(2-(trifluoromethyl)phenyl)urea
MDL No.MFCD05988780
Molecular FormulaC15H16F3N3O2
Molecular Weight327.31
SMILESCC(C)(C)C1=CC(NC(=O)NC2=C(C=CC=C2)C(F)(F)F)=NO1
InChI KeyQLYRYTTVTAYDLF-UHFFFAOYSA-N
Synonym1-(5-(tert-Butyl)isoxazol-3-yl)-3-(2-(trifluoromethyl)phenyl)urea;1-(5-(Tert-butyl)isoxazol-3(2h)-ylidene)-3-(2-(trifluoromethyl)phenyl)urea;Urea, N-[5-(1,1-dimethylethyl)-3-isoxazolyl]-N'-[2-(trifluoromethyl)phenyl]-
CAS No.304440-06-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACCFTS103 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLYAP647 route compound structure diagram
    ACLYAP64755809-36-4 In Stock
  2. Plus
  3. ACOIYN317 route compound structure diagram
    ACOIYN3172285-12-3 In Stock
  4. Then
  5. ACCFTS103 route product structure diagram
    ACCFTS103304440-06-0
Inquiry

2. ACCFTS103 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCFTS103 route product structure diagram
    ACCFTS103304440-06-0
Inquiry

Comments (0)